ABSTRACT
Purpose
To test the effectiveness of a dual–agent-loaded PLGA nanoparticulate drug delivery system containing doxorubicin (DOX) and indocyanine green (ICG) in a DOX-sensitive cell line and two resistant cell lines that have different resistance mechanisms.
Methods
The DOX-sensitive MES-SA uterine sarcoma cell line was used as a negative control. The two resistant cell lines were uterine sarcoma MES-SA/Dx5, which overexpresses the multidrug resistance exporter P-glycoprotein, and ovarian carcinoma SKOV-3, which is less sensitive to doxorubicin due to a p53 gene mutation. The cellular uptake, subcellular localization and cytotoxicity of the two agents when delivered via nanoparticles (NPs) were compared to their free-form administration.
Results
The cellular uptake and cytotoxicity of DOX delivered by NPs were comparable to the free form in MES-SA and SKOV-3, but much higher in MES-SA/Dx5, indicating the capability of the NPs to overcome P-glycoprotein resistance mechanisms. NP-encapsulated ICG showed slightly different subcellular localization, but similar fluorescence intensity when compared to free ICG, and retained the ability to generate heat for hyperthermia delivery.
Conclusion
The dual-agent-loaded system allowed for the simultaneous delivery of hyperthermia and chemotherapy, and this combinational treatment greatly improved cytotoxicity in MES-SA/Dx5 cells and to a lesser extent in SKOV-3 cells.
Similar content being viewed by others
Abbreviations
- DOX:
-
Doxorubicin
- ICG:
-
Indocyanine green
- MDR:
-
Multidrug resistance
- P-gp:
-
P-glycoprotein
- NIR:
-
Near-infrared
- NP:
-
Nanoparticle
- PLGA:
-
Poly (DL-lactide-co-glycolide)
- DMSO:
-
Dimethylsulfoxide
- PVA:
-
Polyvinyl alcohol
- DCM:
-
Dichloromethane
- ICG-DOX-PLGANPs:
-
Poly (DL-lactide-co-glycolide) NPs loaded with indocyanine green and doxorubicin
- DLS:
-
Dynamic light scattering
- SEM:
-
Scanning electron microscopy
- Dx5:
-
MES-SA/Dx5
- FBS:
-
Fetal bovine serum
- ICG-DOX:
-
Nonencapsulated DOX and ICG mixture solution
- DPBS:
-
Dulbecco’s Phosphate Buffered Saline
- NPC:
-
Nuclear pore complex
REFERENCES
Yi C, Gratzl M. Continuous in situ electrochemical monitoring of doxorubicin efflux from sensitive and drug-resistant cancer cells. Biophys J. 1998;75(5):2255–61.
Roninson IB. Molecular mechanism of multidrug resistance in tumor cells. Clin Physiol Biochem. 1987;5(3–4):140–51.
Tan ML, Choong PF, Dass CR. Review: doxorubicin delivery systems based on chitosan for cancer therapy. J Pharm Pharmacol. 2009;61(2):131–42.
Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophthalmol. 2000;45(1):15–27.
Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;54(5):631–51.
McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med. 2003;9(6):713–25.
Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249–57.
Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55(3):329–47.
Vasir JK, Labhasetwar V. Targeted drug delivery in cancer therapy. Technol Cancer Res Treat. 2005;4(4):363–74.
Saxena V, Sadoqi M, Shao J. Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. Int J Pharm. 2006;308(1–2):200–4.
Overgaard J. Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo. Cancer Res. 1976;36(9 pt.1):3077–81.
Tang Y, McGoron AJ. Combined effects of laser-ICG photothermotherapy and doxorubicin chemotherapy on ovarian cancer cells. J Photochem Photobiol B Biol. 2009;97(3):138–44.
Si HY, Li DP, Wang TM, Zhang HL, Ren FY, Xu ZG, et al. Improving the anti-tumor effect of genistein with a biocompatible superparamagnetic drug delivery system. Journal of nanoscience and nanotechnology. Apr;10(4):2325–31.
Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials. 2008;29(29):4012–21.
Xiao X, He Q, Huang K. Possible magnetic multifunctional nanoplatforms in medicine. Med Hypotheses. 2007;68(3):680–2.
Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA. 2003;100(23):13549–54.
Kalambur VS, Longmire EK, Bischof JC. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. Langmuir. 2007;23(24):12329–36.
Park H, Yang J, Lee J, Haam S, Choi IH, Yoo KH. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. ACS Nano. 2009;3(10):2919–26.
O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004;209(2):171–6.
Smart SK, Cassady AI, Lu GQ, Martin DJ. The biocompatibility of carbon nanotubes. Carbon. 2006;44(6):1034–47.
Li Z, Huang P, Zhang X, Lin J, Yang S, Liu B, et al. RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy. Molecular Pharmaceutics. Feb 1;7(1):94–104.
Manchanda R, Fernandez-Fernandez A, Nagesetti A, McGoron AJ. Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents. Colloids and surfaces B, Biointerfaces. Jan 1;75(1):260–7.
Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst. 1991;83(11):757–66.
Prabha S, Zhou WZ, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm. 2002;244(1–2):105–15.
Zolnik BS, Leary PE, Burgess DJ. Elevated temperature accelerated release testing of PLGA microspheres. J Control Release. 2006;112(3):293–300.
Misra R, Sahoo SK. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. Jan 31;39(1-3):152–63.
Sahoo SK, Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm. 2005;2(5):373–83.
Qaddoumi MG, Gukasyan HJ, Davda J, Labhasetwar V, Kim KJ, Lee VH. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis. Mol Vis. 2003;9:559–68.
Wong HL, Bendayan R, Rauth AM, Xue HY, Babakhanian K, Wu XY. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. J Pharmacol Exp Ther. 2006;317(3):1372–81.
Panyam J, Labhasetwar V. Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol Pharm. 2004;1(1):77–84.
Gieseler F, Biersack H, Brieden T, Manderscheid J, Nussler V. Cytotoxicity of anthracyclines: correlation with cellular uptake, intracellular distribution and DNA binding. Ann Hematol. 1994;69 Suppl 1:S13–7.
Belloc F, Lacombe F, Dumain P, Lopez F, Bernard P, Boisseau MR, et al. Intercalation of anthracyclines into living cell DNA analyzed by flow cytometry. Cytometry. 1992;13(8):880–5.
Abels C, Fickweiler S, Weiderer P, Baumler W, Hofstadter F, Landthaler M, et al. Indocyanine green (ICG) and laser irradiation induce photooxidation. Arch Dermatol Res. 2000;292(8):404–11.
Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 2002;16(10):1217–26.
Cartiera MS, Johnson KM, Rajendran V, Caplan MJ, Saltzman WM. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials. 2009;30(14):2790–8.
Tang Y, McGoron AJ. The Role of Temperature Increase Rate in Combinational Hyperthermia Chemotherapy Treatment. Proc. SPIE, Vol. 7565, 75650C (2010); doi:10.1117/12.842587.
Fan S, Twu NF, Wang JA, Yuan RQ, Andres J, Goldberg ID, et al. Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation. Int J Cancer J Int Du Cancer. 1998;77(4):600–9.
Bottini A, Berruti A, Bersiga A, Brizzi MP, Brunelli A, Gorzegno G, et al. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients. Clin Cancer Res. 2000;6(7):2751–8.
Thorburn A, Frankel AE. Apoptosis and anthracycline cardiotoxicity. Mol Cancer Ther. 2006;5(2):197–9.
Sturm I, Rau B, Schlag PM, Wust P, Hildebrandt B, Riess H, et al. Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy. BMC Cancer. 2006;6:124.
Fukami T, Nakasu S, Baba K, Nakajima M, Matsuda M. Hyperthermia induces translocation of apoptosis-inducing factor (AIF) and apoptosis in human glioma cell lines. J Neuro-oncol. 2004;70(3):319–31.
Lee SJ, Jeong JR, Shin SC, Huh YM, Song HT, Suh JS, et al. Intracellular translocation of superparamagnetic iron oxide nanoparticles encapsulated with peptide-conjugated poly(D,L lactide-co-glycolide). Journal of Applied Physics. 2005 May;97(10).
ACKNOWLEDGEMENTS
This work was conducted using the facilities of the Biomedical Engineering Department at Florida International University and partially funded by FLDOH (Grant #08-BB-11), the Biomedical Engineering Young Inventor Award from the Wallace H. Coulter Foundation to R.M., the Florida International University Dissertation Year Fellowship to Y.T., and support from NIH/NIGMS R25 GM061347 to A.F.F.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tang, Y., Lei, T., Manchanda, R. et al. Simultaneous Delivery of Chemotherapeutic and Thermal-Optical Agents to Cancer Cells by a Polymeric (PLGA) Nanocarrier: An In Vitro Study. Pharm Res 27, 2242–2253 (2010). https://doi.org/10.1007/s11095-010-0231-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-010-0231-6